SANTA ANA, Calif., July 24, 2021 /PRNewswire/ -- Johnson & Johnson Vision*, a global leader in eye health and part of the Johnson & Johnson Medical Devices Companies**, today revealed new comparative ...
Please provide your email address to receive an email when new articles are posted on . LipiFlow has consistently demonstrated safety and efficacy in treating meibomian gland dysfunction. The review ...
Please provide your email address to receive an email when new articles are posted on . Researchers found no significant evidence that LipiFlow outperforms other commonly used dry eye disease ...
One adverse event report was listed on the US Food and Drug Administration (FDA) Manufacturer and User Device Facility Experience (MAUDE) database. One person suffered a corneal abrasion 5 days after ...
The LipiFlow system applies heat and gentle pressure to the eyelids to treat dry eyes caused by meibomian gland dysfunction. Two randomised controlled trials showed that the LipiFlow system was at ...